Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer

Recruiting

Early Phase 1

Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Code:

NCT05620342

Conditions

Lung Cancer

Small Cell Lung Carcinoma

Non Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

iC9.GD2.CAR.IL-15 T Infusion

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-04. This information was provided to ClinicalTrials.gov by UNC Lineberger Comprehensive Cancer Center on 2025-03-04.